Retinal Vascular Disease Symposium

Related

• 

  Complications, Compliance, and 2-Year Outcomes After Endolaserless Vitrectomy With Aflibercept Monotherapy for PDR-Related Vitreous Hemorrhage

  Dennis M. Marcus, MD

  Annual Meeting Talks

  2020

• 

  Characteristics and Outcomes of nAMD Patients Managed in US Routine Clinical Practice: Analysis of the IRIS Registry Database

  Anita Barikian, MD

  Annual Meeting Talks

  2022

• 

  Defining a 'Strong' and 'Weak' Response to Anti-VEGF Treatment CI-DME: Retrospective Analysis of 3 DRCR Retina Network Clinical Trials

  Sharon D. Solomon, MD

  Annual Meeting Talks

  2023